Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders

被引：39

作者：

Frederick, Meredith C. ^{[1
,2
]}

Cameron, Michelle H. ^{[1
,2
]}

机构：

[1] Oregon Hlth & Sci Univ, Dept Neurol, 3181 SW Sam Jackson Pk Rd,L226, Portland, OR 97239 USA

[2] Vet Affairs Portland Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Portland, OR 97239 USA

来源：

CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS | 2016年 / 16卷 / 03期

关键词：

Tumefactive multiple sclerosis; Schilder's disease; Marburg; Balo's concentric sclerosis; BALOS CONCENTRIC SCLEROSIS; MARBURG VARIANT; SCHILDERS-DISEASE; BRAIN; DIAGNOSIS; FEATURES; TUMOR; FINGOLIMOD; RITUXIMAB; CRITERIA;

D O I：

10.1007/s11910-016-0626-9

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Tumefactive demyelinating lesions are rare consequences of central nervous system (CNS) idiopathic inflammatory demyelinating diseases. Tumefactive demyelinating lesions pose a diagnostic challenge because they can mimic tumors and abscesses and because they can be caused by a heterogeneous range of disorders. This article reviews the recent literature on the clinical presentation; radiographic features; prognosis; and management of tumefactive demyelinating lesions in multiple sclerosis, acute demyelinating encephalomyelitis, neuromyelitis optica, and the rare variants of multiple sclerosis including Schilder's disease, Marburg acute multiple sclerosis, and Balo's concentric sclerosis.

引用

页码：1 / 7

页数：7

共 58 条

[1] Clinical and radiological characteristics of tumefactive demyelinating lesions: follow-up study [J].

Altintas, A. ;

Petek, B. ;

Isik, N. ;

Terzi, M. ;

Bolukbasi, F. ;

Tavsanli, M. ;

Saip, S. ;

Boz, C. ;

Aydin, T. ;

Arici-Duz, O. ;

Ozer, F. ;

Siva, A. .

MULTIPLE SCLEROSIS JOURNAL, 2012, 18 (10) :1448-1453

[2] Acute demyelination, neuropathological diagnosis, and clinical evolution [J].

Annesley-Williams, D ;

Farrell, MA ;

Staunton, H ;

Brett, FM .

JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2000, 59 (06) :477-489

[3] Schilder's disease: non-invasive diagnosis? [J].

Bacigaluppi, Susanna ;

Polonara, Gabriele ;

Zavanone, Mario L. ;

Campanella, Rolando ;

Branca, Vincenzo ;

Gaini, Sergio M. ;

Tredici, Giovanni ;

Costa, Antonella .

NEUROLOGICAL SCIENCES, 2009, 30 (05) :421-430

[4] Encephalitis periaxialis concentrica [J].

Balo, J .

ARCHIVES OF NEUROLOGY AND PSYCHIATRY, 1928, 19 (02) :242-264

[5] Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis [J].

Barkhof, F ;

Filippi, M ;

Miller, DH ;

Scheltens, P ;

Campi, A ;

Polman, CH ;

Comi, G ;

Ader, HJ ;

Losseff, N ;

Valk, J .

BRAIN, 1997, 120 :2059-2069

[6]

Beniac D R, 1999, Mol Cell Biol Res Commun, V1, P48, DOI 10.1006/mcbr.1999.0111

[7] Massive exacerbation of multiple sclerosis after withdrawal and early restart of treatment with natalizumab [J].

Beume, Lena-Alexandra ;

Dersch, Rick ;

Fuhrer, Hannah ;

Stich, Oliver ;

Rauer, Sebastian ;

Niesen, Wolf D. .

JOURNAL OF CLINICAL NEUROSCIENCE, 2015, 22 (02) :400-401

[8]

Bitsch A, 1999, MULT SCLER, V5, P138, DOI 10.1177/135245859900500302

[9]

Boangher S, 2015, ACTA NEUROL BELG

[10] CADASIL mutation and Balo concentric sclerosis: A link between demyelination and ischemia? [J].

Chitnis, Tanuja ;

Hollmann, Travis J. .

NEUROLOGY, 2012, 78 (03) :221-223

← 1 2 3 4 5 6 →